BROADPEAK (ALBPK.PA) Fundamental Analysis & Valuation

EPA:ALBPK • FR001400AJZ7

2.2 EUR
+0.06 (+2.8%)
Last: Mar 10, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This ALBPK.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

ALBPK gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 34 industry peers in the Communications Equipment industry. Both the profitability and financial health of ALBPK have multiple concerns. ALBPK is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. ALBPK.PA Profitability Analysis

1.1 Basic Checks

  • ALBPK had negative earnings in the past year.
  • ALBPK had a positive operating cash flow in the past year.
  • In multiple years ALBPK reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: ALBPK reported negative operating cash flow in multiple years.
ALBPK.PA Yearly Net Income VS EBIT VS OCF VS FCFALBPK.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

  • The Return On Assets of ALBPK (-2.14%) is comparable to the rest of the industry.
  • The Return On Equity of ALBPK (-5.68%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.14%
ROE -5.68%
ROIC N/A
ROA(3y)-4.48%
ROA(5y)0.39%
ROE(3y)-10.87%
ROE(5y)10.06%
ROIC(3y)N/A
ROIC(5y)N/A
ALBPK.PA Yearly ROA, ROE, ROICALBPK.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

  • The Gross Margin of ALBPK (96.77%) is better than 100.00% of its industry peers.
  • ALBPK's Gross Margin has improved in the last couple of years.
  • ALBPK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 96.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.66%
GM growth 5YN/A
ALBPK.PA Yearly Profit, Operating, Gross MarginsALBPK.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 60 80 100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ALBPK.PA Health Analysis

2.1 Basic Checks

  • ALBPK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALBPK remains at a similar level compared to 1 year ago.
  • ALBPK has a better debt/assets ratio than last year.
ALBPK.PA Yearly Shares OutstandingALBPK.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALBPK.PA Yearly Total Debt VS Total AssetsALBPK.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • ALBPK has an Altman-Z score of 1.18. This is a bad value and indicates that ALBPK is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 1.18, ALBPK perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
  • ALBPK has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.45, ALBPK is not doing good in the industry: 64.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 1.18
ROIC/WACCN/A
WACC8.13%
ALBPK.PA Yearly LT Debt VS Equity VS FCFALBPK.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • ALBPK has a Current Ratio of 1.19. This is a normal value and indicates that ALBPK is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of ALBPK (1.19) is worse than 70.59% of its industry peers.
  • ALBPK has a Quick Ratio of 1.19. This is a normal value and indicates that ALBPK is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of ALBPK (1.19) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19
ALBPK.PA Yearly Current Assets VS Current LiabilitesALBPK.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ALBPK.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 78.22% over the past year.
  • The Revenue has grown by 15.01% in the past year. This is quite good.
  • Measured over the past years, ALBPK shows a small growth in Revenue. The Revenue has been growing by 5.93% on average per year.
EPS 1Y (TTM)78.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.02%
Revenue 1Y (TTM)15.01%
Revenue growth 3Y5.93%
Revenue growth 5YN/A
Sales Q2Q%26.16%

3.2 Future

  • The Earnings Per Share is expected to grow by 42.92% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 9.09% on average over the next years. This is quite good.
EPS Next Y43.55%
EPS Next 2Y50.27%
EPS Next 3Y42.92%
EPS Next 5YN/A
Revenue Next Year12.06%
Revenue Next 2Y9.34%
Revenue Next 3Y9.09%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALBPK.PA Yearly Revenue VS EstimatesALBPK.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALBPK.PA Yearly EPS VS EstimatesALBPK.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

3

4. ALBPK.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALBPK. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 26.70 indicates a quite expensive valuation of ALBPK.
  • Based on the Price/Forward Earnings ratio, ALBPK is valued a bit cheaper than 61.76% of the companies in the same industry.
  • ALBPK's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.39.
Industry RankSector Rank
PE N/A
Fwd PE 26.7
ALBPK.PA Price Earnings VS Forward Price EarningsALBPK.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALBPK indicates a somewhat cheap valuation: ALBPK is cheaper than 76.47% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.51
ALBPK.PA Per share dataALBPK.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • ALBPK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ALBPK's earnings are expected to grow with 42.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.27%
EPS Next 3Y42.92%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALBPK.PA Dividend Analysis

5.1 Amount

  • ALBPK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALBPK.PA Fundamentals: All Metrics, Ratios and Statistics

BROADPEAK

EPA:ALBPK (3/10/2026, 7:00:00 PM)

2.2

+0.06 (+2.8%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners2.39%
Inst Owner ChangeN/A
Ins Owners49.73%
Ins Owner ChangeN/A
Market Cap27.59M
Revenue(TTM)43.87M
Net Income(TTM)-1.04M
Analysts86
Price Target3.42 (55.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 26.7
P/S 0.63
P/FCF N/A
P/OCF 4.52
P/B 1.5
P/tB 100.32
EV/EBITDA 15.51
EPS(TTM)-0.09
EYN/A
EPS(NY)0.08
Fwd EY3.75%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)0.49
OCFY22.13%
SpS3.5
BVpS1.47
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.14%
ROE -5.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 96.77%
FCFM N/A
ROA(3y)-4.48%
ROA(5y)0.39%
ROE(3y)-10.87%
ROE(5y)10.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.66%
GM growth 5YN/A
F-Score6
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 3.5
Cap/Depr 111.77%
Cap/Sales 16.58%
Interest Coverage N/A
Cash Conversion 259.72%
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z 1.18
F-Score6
WACC8.13%
ROIC/WACCN/A
Cap/Depr(3y)283.73%
Cap/Depr(5y)362.99%
Cap/Sales(3y)24.24%
Cap/Sales(5y)18.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.02%
EPS Next Y43.55%
EPS Next 2Y50.27%
EPS Next 3Y42.92%
EPS Next 5YN/A
Revenue 1Y (TTM)15.01%
Revenue growth 3Y5.93%
Revenue growth 5YN/A
Sales Q2Q%26.16%
Revenue Next Year12.06%
Revenue Next 2Y9.34%
Revenue Next 3Y9.09%
Revenue Next 5YN/A
EBIT growth 1Y54.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year182.46%
EBIT Next 3Y54.33%
EBIT Next 5YN/A
FCF growth 1Y84.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.99%
OCF growth 3Y167.99%
OCF growth 5YN/A

BROADPEAK / ALBPK.PA FAQ

What is the fundamental rating for ALBPK stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALBPK.PA.


What is the valuation status of BROADPEAK (ALBPK.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to BROADPEAK (ALBPK.PA). This can be considered as Overvalued.


Can you provide the profitability details for BROADPEAK?

BROADPEAK (ALBPK.PA) has a profitability rating of 3 / 10.


What is the financial health of BROADPEAK (ALBPK.PA) stock?

The financial health rating of BROADPEAK (ALBPK.PA) is 3 / 10.